VEGFA and osteosarcoma: Sheikh et al., (2016) focused in detail on all targeted and molecular therapies to treat osteosarcoma and reported anti-VEGF drugs ineffective in the treatment of osteosarcoma alone; however, they stated that in the second phase of clinical trials to assess the combination of these drugs (Bevacizumab) with chemotherapy is conducted.